anxiety, depression, and brain fog are not character flaws, diagnoses without causes, or inevitable consequences of modern life. They are biological states — and they have biological origins worth finding.
The conventional model of mental health is built on a premise that is increasingly difficult to defend: that anxiety, depression, and cognitive dysfunction originate in the brain and should be treated in the brain — with medications that alter neurotransmitter levels, and therapy that reframes thought patterns. Both have genuine value. But both leave unexamined a body of research that has fundamentally shifted our understanding of where these conditions come from.
A 2025 review in Frontiers in Psychiatry described anxiety and depressive disorders as ‘systemic conditions arising from integrated neural, immune, endocrine, metabolic, and circadian dysregulation — rather than isolated brain-based pathologies.’ That framing, increasingly supported by peer-reviewed evidence, is the framework functional medicine has always worked within. The gut communicates with the brain through the vagus nerve, immune signaling, and neurotransmitter production. The thyroid governs the energy available to every neuron. Cortisol patterns from HPA axis dysregulation shape mood, memory, and fear response. Nutrient deficiencies impair the synthesis of serotonin, dopamine, GABA, and BDNF. These are not alternative theories — they are mechanisms, documented in the literature, that standard psychiatric care rarely investigates.
The brain does not exist in isolation from the body. Inflammation, gut dysbiosis, hormonal disruption, and nutrient depletion reach the brain through well-characterized biological pathways. Mental health that doesn’t improve with medication alone is often a body problem that hasn’t been examined yet.
Functional Medicine Clinical FrameworkKey Takeaways
- 01
Anxiety, depression, and brain fog share biological root drivers — gut dysbiosis, neuroinflammation, HPA axis dysregulation, thyroid dysfunction, and nutrient depletion — that standard psychiatric evaluation does not assess and that medication does not resolve.
- 02
The gut microbiome produces approximately 90% of the body’s serotonin and directly regulates GABA signaling; dysbiosis that disrupts this production is a documented and addressable biological driver of anxiety and depression.
- 03
Approximately one-third of depression patients do not respond adequately to antidepressants; elevated inflammatory markers predict poor medication response, suggesting that for many patients, depression is fundamentally an inflammatory condition being treated as a neurotransmitter problem.
- 04
Brain fog has multiple simultaneous, treatable causes — thyroid dysfunction, B12 and vitamin D deficiency, insulin resistance, neuroinflammation, and sleep dysregulation — that are only identifiable through comprehensive multi-system testing.
Anxiety
Anxiety disorders are the most prevalent mental health conditions in the United States, affecting an estimated 40 million adults annually. Around 23% of US adults experience any mental illness in a given year, with anxiety disorders representing the largest share. First-line treatment is typically an SSRI or SNRI, often alongside cognitive behavioral therapy. For many patients, this is helpful. For a significant subset, it is insufficient — and the reason it is insufficient is rarely investigated.
The biological drivers of anxiety that functional medicine assesses go well beyond serotonin. The gut microbiome produces roughly 90% of the body’s serotonin and significantly influences GABA — the primary inhibitory neurotransmitter. Gut dysbiosis disrupts both. The HPA axis, chronically dysregulated by sustained stress, produces cortisol patterns that maintain a physiological state of hypervigilance independent of actual threat. Magnesium deficiency — among the most common nutrient deficiencies in Western populations — directly impairs GABA receptor function and raises the nervous system’s excitability threshold. Thyroid dysfunction, blood sugar dysregulation, and neuroinflammation from any source all contribute to anxious arousal that medication adjusts but cannot resolve.
Our functional evaluation of anxiety includes a comprehensive assessment of the biology most likely to be driving or maintaining it: gut microbiome and intestinal permeability, 4-point salivary cortisol and HPA axis function, full thyroid panel, fasting insulin and glucose stability, RBC magnesium and comprehensive nutrient status, inflammatory markers, and sex hormone assessment. Treatment is targeted to the specific findings — addressing the biological terrain that is sustaining the anxiety response rather than only dampening its expression.
Depression
Major depressive disorder affects roughly 21 million US adults annually — approximately 8.3% of the population. Treatment response to antidepressants is meaningful for many patients but incomplete for many more: approximately one third of patients with major depression do not respond adequately to first-line medication, and the majority who do respond continue to experience residual symptoms. The biological reasons for this treatment gap are increasingly well understood.
According to 2025 research in Frontiers in Psychiatry, major depressive disorder is increasingly described through the lens of neuroinflammation — specifically, microglial activation in the central nervous system driven in part by gut dysbiosis, increased intestinal permeability, and systemic inflammatory signaling. The inflammatory cytokines TNF-alpha, IL-6, and IL-1beta impair tryptophan conversion to serotonin, reduce BDNF (the growth factor responsible for neuroplasticity and hippocampal health), and activate the kynurenine pathway — generating neurotoxic metabolites that directly impair mood and cognition. Antidepressants do not address any of these mechanisms.
Functional medicine evaluation of depression investigates the inflammatory and metabolic terrain directly: gut microbiome and permeability, inflammatory cytokines and hs-CRP, thyroid function (hypothyroidism is among the most common reversible causes of depression and is frequently missed on TSH-only screening), sex hormone status (testosterone deficiency in both men and women produces depression that antidepressants rarely resolve), vitamin D (a neurosteroid with direct roles in serotonin synthesis and mood regulation), B12 and folate (required for methylation and neurotransmitter production), omega-3 index, and cortisol patterning. Each finding becomes a treatment target — not just a number to note.
The Inflammation Model of Depression
A Third of Patients Don't Respond to Antidepressants — Here Is Why Biology Matters
Elevated inflammatory markers predict poor antidepressant response. Patients with high hs-CRP are significantly less likely to respond to SSRIs and more likely to benefit from anti-inflammatory interventions. This is not a niche finding — it has been replicated across multiple studies and suggests that for a substantial subset of depressed patients, the condition is fundamentally an inflammatory disease being treated as a neurotransmitter problem.
Brain Fog
Brain fog is not a diagnosis — it is a symptom cluster: slowed thinking, difficulty concentrating, impaired word retrieval, poor short-term memory, and a pervasive sense of mental dullness that patients often describe as ‘thinking through cotton wool.’ It is dismissed by conventional medicine more often than it is investigated, partly because there is no single lab test for it and partly because its causes are distributed across systems that standard specialty care evaluates in isolation.
The most consistently documented biological drivers of brain fog include thyroid dysfunction — particularly subclinical hypothyroidism, where TSH may remain within the standard reference range while free T3 is insufficient for normal neurological function; vitamin B12 deficiency (standard deficiency cutoffs are set far below what research associates with optimal neurological performance); vitamin D deficiency, affecting an estimated 42% of US adults and strongly linked to cognitive symptoms; blood sugar dysregulation and insulin resistance, which deprive the brain of stable fuel; neuroinflammation from gut dysbiosis or systemic inflammation; sleep disruption; and HPA axis dysregulation with its direct effects on hippocampal function and memory consolidation.
Because brain fog is multi-causal, its investigation requires a multi-system approach. Our evaluation includes the full thyroid panel (TSH, free T3, free T4, reverse T3), vitamin D, B12, RBC magnesium, iron and ferritin, fasting insulin and glucose, inflammatory markers, gut microbiome and permeability, cortisol rhythm, and sex hormone panel. In many cases, patients with years of unexplained cognitive symptoms have multiple simultaneous findings — each contributing to the fog, each individually addressable.
40M
US adults with anxiety disorders — the most prevalent mental health condition
NIMH / USAHS 2025
21M
US adults with at least one major depressive episode annually — 8.3% of the population
NIMH 2021
~â…“
Of depression patients don't respond adequately to first-line antidepressants
STAR*D trial data
42%
Of US adults are vitamin D deficient — one of the most common cognitive and mood drivers
NHANES data
How These Three Conditions Overlap
Anxiety, depression, and brain fog rarely arrive alone. They share the same upstream biology — gut dysbiosis disrupting neurotransmitter production and driving neuroinflammation; HPA axis dysregulation maintaining a stress-response physiology that impairs mood, cognition, and sleep simultaneously; thyroid dysfunction slowing every neurological process; nutrient deficiencies depleting the raw materials required for neurotransmitter synthesis; and blood sugar instability creating the hourly fluctuations in brain fuel that produce anxiety spikes, mood crashes, and cognitive blunting.
This convergence is why a patient who presents with anxiety, depression, and brain fog simultaneously — a combination that is common — is not three separate diagnoses requiring three separate specialists. They are three expressions of the same biological disruption. Treating the anxiety with one medication, the depression with another, and ignoring the brain fog entirely addresses none of the shared root causes.
Functional medicine maps the convergence. We identify the specific combination of gut, inflammatory, hormonal, nutrient, and metabolic findings present in your biology and treat the shared terrain. When the neuroinflammatory load decreases, the gut microbiome improves, the thyroid functions optimally, and nutrient depletions are corrected — all three symptom clusters typically improve together, because they share the same source.
Important
Functional Medicine Complements — Does Not Replace — Mental Health Care
We work alongside psychiatrists, psychologists, and therapists — not instead of them. For patients with moderate-to-severe depression or anxiety, psychiatric medication and evidence-based therapy are often essential components of care and should not be discontinued without clinical supervision. Our role is to investigate and address the biological factors that maintain or amplify these conditions, often improving treatment response and reducing medication burden over time. We never advise stopping psychiatric medication without coordination with your prescribing clinician.
What a Functional Evaluation Looks Like
01
Deep History & Timeline Mapping
When did symptoms begin relative to life events, infections, dietary changes, medication use, or stressors? The sequence of onset frequently reveals the initiating trigger — a course of antibiotics that disrupted the microbiome, a period of sustained stress that dysregulated the HPA axis, a pregnancy or thyroid event that altered the hormonal landscape.
02
Gut Microbiome & Neuroinflammation Assessment
Comprehensive stool analysis, intestinal permeability markers (zonulin, LPS antibodies), and inflammatory cytokine panel. The gut-brain axis is the single most important system to evaluate in unexplained or treatment-resistant anxiety and depression.
03
Full Hormonal & Thyroid Panel
TSH, free T3, free T4, reverse T3, TPO antibodies. Sex hormone panel (estradiol, progesterone, testosterone, DHEA-S). Four-point salivary or DUTCH cortisol assessment. Blood sugar and insulin. Each of these governs neurological function in ways that standard psychiatric evaluation does not assess.
04
Nutrient Status for Neurotransmitter Production
Vitamin D (25-OH), B12, folate, RBC magnesium, iron and ferritin, omega-3 index, zinc, and B6. These are the raw materials for serotonin, dopamine, GABA, BDNF, and the methylation pathways that govern mood regulation. Deficiencies are common, underdiagnosed, and directly causal.
The question is never whether the mind affects the body or the body affects the mind. The question is which biological systems are dysregulated, and in what sequence — because that determines where to start.
Functional Medicine Clinical PrincipleReady to Investigate the Biology?
Book a Mental Health Consultation
If you are living with anxiety, depression, or brain fog that has not fully responded to conventional care — or that you suspect has biological drivers worth investigating — a functional medicine consultation provides the depth of evaluation that standard care does not offer. We see patients throughout Florida, in-person and via telemedicine.
QDoes functional medicine mean stopping antidepressants or anti-anxiety medication?
No — and we want to be unambiguous about this. Psychiatric medication is often appropriate, sometimes essential, and should never be discontinued without clinical supervision. What functional medicine adds is an investigation of the biological factors that may be maintaining or amplifying your symptoms despite medication. Addressing those factors frequently improves medication response and may, over time and under physician coordination, allow for dose reduction. But that is a gradual, supervised process — never an abrupt change.
QHow does gut health relate to anxiety and depression?
The gut produces roughly 90% of the body’s serotonin and significantly influences GABA, the primary calming neurotransmitter. Gut dysbiosis — an imbalance in the microbial community — disrupts both. Increased intestinal permeability allows inflammatory molecules into circulation that activate microglia in the brain and impair neurotransmitter production. The vagus nerve carries bidirectional signals between the gut and the brain. These are not metaphors — they are documented physiological mechanisms that explain why gut-directed interventions produce measurable improvements in anxiety and depressive symptoms in peer-reviewed trials.
QI have been told my thyroid is normal, but I have depression and brain fog. Could my thyroid still be involved?
Yes — frequently. A normal TSH confirms that the pituitary is signaling appropriately but says nothing about free T3 availability at the cellular level, reverse T3 blockade, or autoimmune antibody activity. Subclinical hypothyroidism, where TSH is in the high-normal range, is associated with depression, cognitive slowing, and brain fog in peer-reviewed research. We run a full 8-marker thyroid panel and interpret results against optimal functional ranges rather than population averages, because the goal is your neurological function — not a number within a wide statistical band.
QWhat is the connection between inflammation and depression?
Elevated inflammatory cytokines — particularly TNF-alpha, IL-6, and IL-1beta — impair the conversion of tryptophan to serotonin, reduce BDNF (the growth factor that supports hippocampal health and neuroplasticity), and redirect tryptophan metabolism toward neurotoxic compounds via the kynurenine pathway. Studies have consistently found that patients with elevated hs-CRP are significantly less likely to respond to SSRIs. This is why we measure inflammatory markers in every mental health evaluation and why anti-inflammatory dietary, gut, and lifestyle interventions are central to our treatment protocols.
QCan functional medicine help with brain fog that started after COVID?
Yes — post-COVID cognitive symptoms, commonly called long COVID brain fog, appear to involve persistent microglial activation, mitochondrial dysfunction, disrupted gut microbiome, and autonomic nervous system dysregulation. While the mechanisms are still being characterized, they overlap substantially with the functional drivers of brain fog from other causes — and the same assessment and treatment framework applies. Many post-COVID patients have responded to protocols addressing neuroinflammation, gut health, nutrient repletion, and pacing-based energy management.
